Redirecting Poor Sleep Drivers of Early Cardiovascular Disease
Launched by NATIONAL UNIVERSITY OF SINGAPORE · Apr 22, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Redirecting Poor Sleep Drivers of Early Cardiovascular Disease," is studying how sleep health affects heart health. Researchers want to understand the link between poor sleep and conditions that can lead to heart disease, such as high blood pressure and high cholesterol. In Singapore, where many people struggle with sleep, it’s especially important to explore how sleep issues might impact heart health. The study will involve tracking sleep patterns using a special ring and answering questions through a smartphone app, while also gathering detailed heart health information.
To join the study, participants should be between 14 and 25 years old and be willing to wear the sleep-tracking ring. They should also have one or more of the following conditions: high blood pressure, high cholesterol, fatty liver, a family history of heart disease or stroke, or obesity. However, individuals with a history of heart attack, stroke, or certain heart devices like pacemakers cannot participate. Those who take part can expect to help researchers learn how improving sleep might help prevent heart problems. This trial is a chance to contribute to important health research that could benefit many people.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Willing to wear a ring
- * Have any of the following conditions:
- • High blood pressure
- • High cholesterol
- • Fatty liver
- • Family history of heart diseases or stroke.
- • Obesity
- Exclusion Criteria:
- • Prior history of heart attack or stroke or balloon angioplasty/stent placement
- • Restricted peripheral circulation (e.g., Raynaud's disease)
- • Pacemakers
About National University Of Singapore
The National University of Singapore (NUS) is a leading global research university recognized for its commitment to advancing scientific knowledge and fostering innovation in healthcare. With a strong emphasis on interdisciplinary collaboration, NUS conducts cutting-edge clinical trials aimed at addressing critical health challenges and improving patient outcomes. The university's state-of-the-art facilities, coupled with its team of renowned researchers and clinicians, enable the development and evaluation of novel therapies and interventions. NUS is dedicated to translating research findings into practical applications, ultimately enhancing the quality of care and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported